Lv3
240 积分 2024-02-19 加入
A guide to CAR T cell therapies: development, current status and future prospects
7天前
已完结
Long-term outcomes following CAR T cell therapy: what we know so far
1个月前
已完结
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence
1个月前
已完结
PD-1 signaling serves a dual role in suppressing T cell activation but also in protecting from activation-induced cell death
2个月前
已完结
Abstract 5465: A novel CD3 VHH—based multi-specific T cell engager platform and multiple leads for gastric cancer and auto-immune disease
2个月前
已完结
Central Dogma of Molecular Biology
2个月前
已完结
984 Novel anti-CD3 heavy chain-only antibodies for use in T-cell engaging immunotherapeutics
2个月前
已关闭
Codon optimality, bias and usage in translation and mRNA decay
2个月前
已完结
Condon Optimization: Codon Optimization of Therapeutic Proteins: Suggested Criteria for Increased Efficacy and Safety
2个月前
已完结
Cancer therapy with antibodies
2个月前
已完结
皖公网安备34019202002308
